Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001183740-22-000002
Filing Date
2022-01-05
Accepted
2022-01-04 18:35:52
Documents
3
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 f6k-20220104drug.htm 6-K 5126
2 NEWS RELEASE ex991-20220104drug.htm EX-99.1 9209
3 ex99120220104drug_1.jpg GRAPHIC 2115
  Complete submission text file 0001183740-22-000002.txt   18351
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 22508385
SIC: 2834 Pharmaceutical Preparations